Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHY906 plus Capecitabine in Advanced HCC
NCT00076609Phase 2Completed
- Sponsor
- PhytoCeutica
- Start
- Oct 2003
- Modality
- Botanical Extract
- Countries
- 2
01
Overview
A Phase 2 trial of PHY906 in hepatocellular carcinoma (HCC), sponsored by PhytoCeutica. Started Oct 2003; status: completed.
02
Drugs
PHY906
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00076609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00076609.